CWG
C WorldWide Group Portfolio holdings
AUM
$7.38B
This Quarter Return
+0.21%
1 Year Return
+18.35%
3 Year Return
+71.53%
5 Year Return
+105.42%
10 Year Return
+360.65%
AUM
$5.18B
AUM Growth
+$5.18B
(-8.6%)
Cap. Flow
-$397M
Cap. Flow
% of AUM
-7.66%
Top 10 Holdings %
Top 10 Hldgs %
64.56%
Holding
133
New
8
Increased
37
Reduced
60
Closed
9
Top Buys
| 1 |
Philip Morris
PM
|
$162M |
| 2 |
FRC
First Republic Bank
FRC
|
$37M |
| 3 |
Citigroup
C
|
$36M |
| 4 |
TSMC
TSM
|
$16.1M |
| 5 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$14.5M |
Top Sells
| 1 |
Dollar General
DG
|
$274M |
| 2 |
McKesson
MCK
|
$226M |
| 3 |
Visa
V
|
$92.9M |
| 4 |
CVS Health
CVS
|
$17.1M |
| 5 |
Meta Platforms (Facebook)
META
|
$13.6M |
Sector Composition
| 1 | Financials | 26.52% |
| 2 | Healthcare | 19.99% |
| 3 | Consumer Discretionary | 17.87% |
| 4 | Communication Services | 13.4% |
| 5 | Consumer Staples | 8.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Amgen
AMGN
$153B
| $23.9M | 0.46% |
163,323
-23,015
| -12% | -$3.36M |
|
|
AGN
27
DELISTED
Allergan plc
AGN
| $22.8M | 0.44% |
108,596
-8,946
| -8% | -$1.88M |
|
28
Merck
MRK
$210B
| $20.5M | 0.4% |
348,200
+9,803
| +3% | +$577K |
|
|
SHPG
29
DELISTED
Shire pic
SHPG
| $19.8M | 0.38% |
116,204
-13,970
| -11% | -$2.38M |
|
30
Cigna
CI
$80.2B
| $16.2M | 0.31% |
121,728
-8,572
| -7% | -$1.14M |
|
31
BioMarin Pharmaceuticals
BMRN
$11.3B
| $15.3M | 0.3% |
185,224
-6,961
| -4% | -$577K |
|
|
CLVS
32
DELISTED
Clovis Oncology, Inc.
CLVS
| $14.5M | 0.28% |
+325,505
| New | +$14.5M |
|
33
Centene
CNC
$14.8B
| $14.1M | 0.27% |
250,018
-28,542
| -10% | -$1.61M |
|
34
Incyte
INCY
$17B
| $12.6M | 0.24% |
126,132
+85,132
| +208% | +$8.54M |
|
35
Glaukos
GKOS
$5.42B
| $12.4M | 0.24% |
362,501
+22,501
| +7% | +$772K |
|
36
HCA Healthcare
HCA
$95.4B
| $11M | 0.21% |
148,885
+3,810
| +3% | +$282K |
|
37
Nike
NKE
$110B
| $11M | 0.21% |
216,230
+14,350
| +7% | +$729K |
|
38
Eli Lilly
LLY
$661B
| $10.6M | 0.2% |
143,995
+136,895
| +1,928% | +$10.1M |
|
39
Alphabet (Google) Class A
GOOGL
$2.79T
| $10.4M | 0.2% |
13,111
-3,190
| -20% | -$2.53M |
|
40
Jazz Pharmaceuticals
JAZZ
$7.99B
| $10.4M | 0.2% |
94,972
+1,385
| +1% | +$151K |
|
|
TSRO
41
DELISTED
TESARO, Inc.
TSRO
| $10M | 0.19% |
74,612
+68,712
| +1,165% | +$9.24M |
|
42
Edwards Lifesciences
EW
$47.7B
| $9.91M | 0.19% |
+105,728
| New | +$9.91M |
|
43
Teva Pharmaceuticals
TEVA
$21.5B
| $9.9M | 0.19% |
273,050
+8,050
| +3% | +$292K |
|
44
Mondelez International
MDLZ
$79.3B
| $8.25M | 0.16% |
186,169
+93,246
| +100% | +$4.13M |
|
45
Viatris
VTRS
$12.3B
| $8.16M | 0.16% |
+213,791
| New | +$8.16M |
|
46
Microsoft
MSFT
$3.76T
| $7.99M | 0.15% |
128,540
+69,946
| +119% | +$4.35M |
|
47
Starbucks
SBUX
$99.2B
| $7.98M | 0.15% |
143,746
+78,220
| +119% | +$4.34M |
|
48
Exelixis
EXEL
$9.95B
| $6.92M | 0.13% |
464,228
+14,228
| +3% | +$212K |
|
49
Colgate-Palmolive
CL
$67.7B
| $6.51M | 0.13% |
99,479
+54,055
| +119% | +$3.54M |
|
50
DaVita
DVA
$9.72B
| $6.35M | 0.12% |
98,877
+3,186
| +3% | +$205K |
|